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In recent years, our knowledge surrounding mammalian mitochondrial DNA (mtDNA) damage and repair
has increased signiﬁcantly. Greater insights into the factors that govern mtDNA repair are being eluci-
dated, thus contributing to an increase in our understanding year on year. In this short review two en-
zymes, tyrosyl-DNA-phosphodiesterase 1 (TDP1) and aprataxin (APTX), involved in mitochondrial single
strand break repair (SSBR) are discussed. The background into the identiﬁcation of these enzymes in
mtDNA repair is communicated with further deliberation into some of the speciﬁcs relating to the import
of these enzymes into the mitochondrion. With the discovery of these enzymes in mitochondria comes
the probability that other mechanisms underlying mtDNA repair are yet to be fully understood, suggesting
there is much left to discover when shaping our understanding of this relatively undeﬁned subject.
 2014 Elsevier Masson SAS. All rights reserved.1. Introduction
Mitochondria are organelles that are integral to viability of eu-
karyotes. These organelles have retained their own genome
(mtDNA) in most species, which is present in multiple copies, is
often maternally inherited, and in man (the focus of this review) is
approximately 16.5 kb [1,2]. Mutations in mtDNA are known to
accumulate during the normal ageing process, which can be
accompanied by dysfunction of the machinery that couples ATP
synthesis to cellular respiration (OXPHOS) [3]. For some time it was
not known whether these mutations contributed to the ageing
phenotype or whether these changes were just a consequence of
the normal ageing process. The development of the mtDNA
mutator mouse generated new and intriguing data that has since
proven to be hugely inﬂuential in the understanding of the role of
mtDNA mutations in ageing and disease [3,4]. While the study of
mtDNAmutations is on-going and of great importance, the study of
physical damage to mtDNA that may cause mutations or genome
instability is a ﬁeld that is still relatively undeﬁned.
Initial investigations of mtDNA repair reported the absence of
pyrimidine dimer resolution following ultra violet (UV) irradiation
of mammalian cells, which may have led to the general assumption
within the ﬁeld that mitochondria did not possess any DNA repair
capabilities [5]. This assumption remained until it wasnse (http://creativecommons.
.
eagher).
son SAS. All rights reserved.demonstrated that a variety of mechanisms exist to repair, or
tolerate, mtDNA damage [6e14]. From such studies, a multitude of
proteins involved in mtDNA repair have been identiﬁed [15],
underlining our gross underestimation of themtDNA repair capacity
in previous years. The focus of this review will be to discuss two
recently identiﬁed members of the mtDNA repair network; tyrosyl-
DNA-phosphodiesterase 1 (TDP1) [12] and aprataxin (APTX) [13].2. Single strand break repair in mitochondria
The process of SSBR is required in response to DNA damage
caused by a multitude of sources with the most common source
being reactive oxygen species (ROS) [16,17]. In such cases, bases can
be damaged resulting in modiﬁcation of the oxidised base leading
to a single strand break (SSB), or when the oxidised based is
removed through base excision repair (BER). The result is an SSB
that requires ligation to restore DNA to its original form [16,17].
Mitochondria are a signiﬁcant contributor to the generation of
endogenous ROS. It is likely that mtDNA is susceptible to damage
from endogenous ROS and that repair mechanisms are necessary as
a protectivemeasure. This has been generally accepted, asmtDNA is
not covered by protective histones, but it must be mentioned that
the general mtDNA binding protein TFAM is present at sufﬁcient
levels to fully coat mtDNA and promote condensation of the
genome [18]. Of the repair mechanisms that have been described in
mitochondria, BER is the most documented. SSBR is often consid-
ered a subpathway of BER due to end processing events to restore
the 50 and 30 termini of the DNA to phosphate (50-P) and hydroxyl
(30-OH), respectively, before ligation proceeds [19]. However, there
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but is not necessarily preceded by the other steps of BER i.e.
removal of a damaged base and cleavage at an abasic (AP) site [16].
Such instances can include those that require the activity of TDP1
and APTX [16].
DNA cleavage is not only initiated by ROS-induced damage. For
example the mitochondrial topoisomerase (TOP1MT) ordinarily
forms a transient nick in mtDNA which is thought to have a role in
regulating mtDNA replication [20,21]. However, on occasion
TOP1MT can collide with DNA or RNA polymerases resulting in the
aberrant resolution of the DNA:TOP1MT structure, with the
TOP1MT remaining covalently attached to the DNA [16,21].
Following proteolytic degradation of the attached TOP1MT, a
tyrosine residue remains bound at the 30 end of DNA via a phos-
photyrosine bond (30-PY) [16]. TDP1 is then required to resolve the
30-PY in an end processing step that can be distinct from the other
steps of BER. Recently, it has also been demonstrated that TDP1 is
capable of repairing several 30 lesions induced by chain terminating
nucleoside analogues (CTNAs) [22]. Abortive ligase activity at a site
adjacent to an existing lesion causes the covalent attachment of
adenine monophosphate (AMP) to the 50 end of mtDNA (50-AMP).
This unusual adduct needs to be removed by aprataxin (APTX) [16].
Fig. 1 illustrates these examples of SSBs and the mechanism of ac-
tion of APTX and TDP1 to repair these lesions.
Failure to repair these lesions could have implications in
genome stability as SSBs may progress to double strand breaks
(DSBs), which could cause DNA instability and/or impaired repli-
cation and gene expression from themitochondrial genome [15,16].
Mutations in APTX and TDP1 have been reported to cause both
ataxia with oculomotor apraxia type 1 (AOA1, for APTX) [23] and
spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1, for
TDP1) [24] with both presenting with ataxia, a feature often,
although not exclusively, associated with mitochondrial disease
[25]. Due to this phenomenon, it has been suggested that both
AOA1 and SCAN1 are primarily mitochondrial disorders [19,26].
However, both APTX and TDP1 activity were originally identiﬁed in
the nucleus with their involvement in SSBR of nDNA being exten-
sively studied in relation to both these diseases, and it is only
recently that the presence and activity of APTX and TDP1 have been
identiﬁed in the mitochondrion. This data is more consistent with
both defective nuclear DNA (nDNA) andmtDNA repair contributing
to the progression of each disease [26e28].
3. How are these enzymes imported into mitochondria?
Despite any debate over whether defective SSBR in the nucleus
or mitochondrion is the primary cause of AOA1 and SCAN1, theFig. 1. Mechanism of action of APTX and TDP1. (A) 50-AMP lesion caused by abortive ligas
phosphate bond releasing AMP and leaving behind 50-P ready for re-ligation. (B) 30-PY gene
leaving behind 30-P that is processed further by a phosphatase restoring the mtDNA to 30Oidentiﬁcation of APTX and TDP1 as factors also found in mito-
chondria predicts novel members of the mtDNA repair network.
One intriguing aspect surrounding TDP1 activity in mitochondria is
how it is imported into themitochondrion given that no N-terminal
presequence is apparent, and there is little evidence to suggest a
mitochondrial-speciﬁc isoform.
Unlike TDP1, an alternatively-spliced isoform of APTXwas found
to contain a 14 amino acid (14-aa) N-terminal sequence with a high
relative potential of being a mitochondrial targeting sequence
(MTS) [13], as predicted using MitoProt [29]. Similar to APTX,
alternative splicing generates N-terminal targeting sequences to
direct a number of other mtDNA repair enzymes to the mito-
chondrion, such as uracil DNA-glycosylase 1 (UNG1) and 8-
oxoguanine-DNA glycosylase 1 (OGG1). This alternative splicing
leads to targeting of these proteins to both nuclear and mito-
chondrial compartments where each isoform has a distinct mo-
lecular weight. It is often the case that in these circumstances the
MTS is cleaved upon entry into the mitochondrion by a mito-
chondrial processing peptidase (MPP) [30]. However, with TDP1
there is no obvious N-terminal MTS despite a clear demonstration
of its presence and activity in mitochondria, which suggests
another import mechanism [12]. Although this is not necessarily a
new conceptual problem with mitochondrial import for other
proteins occurring without an N-terminal MTS it is still a relevant
issue that requires addressing [31]. For the mitochondrial DNA
ligase (LIG3a), import into mitochondria is achieved by providing
anMTS through the use of an upstream translation initiation codon.
The resultant MTS is cleaved on mitochondrial entry, such that the
mature protein has the same molecular weight as in the nucleus
[32]. More recently, a similar targeting scenario was discovered for
the mitochondrial Flap endonuclease 1 (FEN1, or FENMIT to the
authors) or the oligoribonuclease REXO2 where a ‘cryptic’ targeting
signal from alternative translation initiation generates a truncated
isoform of this protein that permits import [33,34]. An earlier
publication from the former group based heavily on in silico ana-
lyses identiﬁed more than 150 putative mitochondrial proteins
with similar sequences; most of which had not yet been identiﬁed
in mitochondria [35]. Although quite a comprehensive list of pro-
teins was produced from this study TDP1 was not included among
them leaving the mystery surrounding the entry of this protein into
mitochondria unanswered (Fig. 2).
Year on year, novel mitochondrial proteins are identiﬁed that
have a variety of functions, some of which include those implicated
in mtDNA repair/maintenance. The recent publications regarding
the alternative translation initiation sites suggest that prediction of
mitochondrial localisation for a protein maybe more complex than
thought [35].e activity adjacent to an existing lesion is repaired by APTX, which cleaves the pyro-
rated from the collision of TOP1MT with DNA or RNA polymerases is removed by TDP1
H and primed for ligation [16].
Fig. 2. Unknown mechanism for TDP1 import into mitochondria. Illustration of
mitochondrial import of APTX and TDP1 following transcription from nDNA and
translation in the cytosol. APTX contains a 14-aa N-terminal MTS and therefore enters
the mitochondrion by this whereas TDP1 has not been found to contain an MTS and so
the mechanism by which this protein enters mitochondria has yet to be elucidated.
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When reﬂecting on the mechanisms of mtDNA repair; is it likely
that all themajor players have been identiﬁed? Almost certainly no,
but to what extent does mtDNA repair, or absence of it, impact in
disease and ageing? One consideration when pursuing the study of
the involvement of TDP1 and APTX in mitochondria was that mu-
tations in the genes encoding both these proteins are linked to
diseases that include ataxia [16], which as stated above is a com-
mon feature of mitochondrial disease [25]. This has led to the
suggestion that the mtDNA damage caused from the lack of activity
of these enzymes may be the primary cause of both SCAN1 and
AOA1 [26]. When considering options for investigating mtDNA
repair further it may be pertinent to study enzymes that are linked
to disorders with typical phenotypes of mitochondrial disease,
although many mutations in genes encoding DNA repair enzymes
cause a predisposition to cancer [16].
Another point for consideration with reference to mtDNA
maintenance is the capability of the organelle to tolerate damage to
its genome without necessarily requiring the active repair of the
DNA itself. In vitro analyses into the ability of the mitochondrial
DNA polymerase (polymerase g) indicated that the bypass of UV-
induced cyclobutane thymine dimers was possible [14]. In this
study the main problem caused by these dimers was replication
stalling, however, when the lesions were bypassed, misincorpora-
tion of nucleotides could be observed, suggesting a damage toler-
ance mechanism of repair [14]. This then suggests a mechanism of
point mutation/deletion formation that is most likely preferential
to replication stalling [14].
One ﬁnal point with regard to the discovery of novel mtDNA
repair/tolerance mechanisms in mitochondria is to echo some of
the comments made by our colleagues in relation to a comparative
long/short range PCR based method to measure mtDNA damage
[19]. This method uses a combination of two semi quantitative
PCR’s and should therefore be used with caution when attempting
to ascertain the exact role of an enzyme in mtDNA repair [19]. With
sound analyses in future investigations into the mtDNA repair
network, it may well be possible to establish the exact involvement
of mtDNA damage in disease and ageing.
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